Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

65.13
-1.6430-2.46%
Post-market: 65.08-0.0470-0.07%16:15 EDT
Volume:41.27K
Turnover:2.69M
Market Cap:92.79M
PE:- -
High:66.06
Open:66.06
Low:64.03
Close:66.77
52wk High:66.88
52wk Low:36.00
Shares:1.42M
Float Shares:1.42M
Volume Ratio:1.40
T/O Rate:2.90%
Dividend:0.65
Dividend Rate:0.99%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

ETF Daily | MRNX Soars 352%; MRNY Surges 169%; TEMC, TEMT Jump 48%; NUGT Climbs 18%; Gold Miners and Biotech Lead

ETF Tracker
·
Aug 20

Moderna Shares Surge 177% on Promising Cancer Vaccine Data, Crushing Short Sellers with $5.5 Billion in Losses

Stock News
·
Aug 20

Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units

TIPRANKS
·
Aug 20

Option Focus | Moderna's $525K Bear Call Spread and $1.67M Long-Dated Put Buy Reveal Institutions Bracing for a Major Downside Move

Option Witch
·
Aug 20

NASD Most Active Issues

Dow Jones
·
Aug 20

One Great Chart: Moderna Surge Makes S&P History

Dow Jones
·
Aug 20

Moderna price target raised to $89 from $39 at Morgan Stanley

TIPRANKS
·
Aug 20

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

Moderna Closes up Nearly 177%, Best Performer in the S&P 500 Today

Dow Jones
·
Aug 20

US Stocks Close: Dow Rises Over 120 Points, SOX Drops 2%; Memory Stocks Lead Losses, SanDisk Falls 3.5%, Moderna Surges 177%

TradingKey
·
Aug 20

US Closing Bell | Unable to generate due to lack of news data

US Closing Bell
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Scorpion Capital Says it is Short Twist Bioscience

Reuters
·
Aug 20

Scorpion Capital: We are Short Twist Biosciences

THOMSON REUTERS
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20